Abstract
The U.S. Food and Drug Administration (FDA) late last month approved a medication called Exxua (gepirone) for the treatment of major depression in adults. Gepirone is in the same class of medications as the anti‐anxiety medication buspirone, according to an American Psychiatric Association Psychiatric News Alert.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
